Today's maintenance is complete. close

Support

Support Options

Submit a Support Ticket

 

BME 695N Lecture 5: Cell Targeting

By James Leary

Basic Medical Sciences and Biomedical Engineering, Purdue University, West Lafayette, IN

Published on

Abstract

Outline:
  1. Overview: targeting nanosystems to cells
    1. Antibody targeting
    2. Peptide targeting
    3. Aptamer targeting
  2. Antibodies – polyclonal and monoclonal
    1. Where do antibodies come from – in nature?
    2. How do we make them in the laboratory?
    3. Monoclonal antibodies
    4. Therapy problems with mouse monoclonal antibodies
    5. “Humanizing” monoclonal antibodies to reduce adverse host immune reactions
    6. Why antibodies may not be a good overall choices for targeting nanosystems to cells
  3. Peptide targeting
    1. How does a peptide target?
    2. Examples of peptide targeting
    3. Creating new peptides by random peptide phage display libraries
    4. High-throughput screening of those peptide libraries
    5. Advantages and disadvantages of peptide targeting
  4. Aptamer targeting
    1. What are aptamers and how do they target?
    2. Some different types of aptamers
    3. How do you make aptamers?
    4. How do you screen for useful aptamers?

References

Cite this work

Researchers should cite this work as follows:

  • James Leary (2007), "BME 695N Lecture 5: Cell Targeting," http://nanohub.org/resources/3176.

    BibTex | EndNote

Time

Location

Biomedical Engineering Building, Room 1083

Tags

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.